Imagine dedicating your life to science. That is what happened here at the Instituto Leloir. It stands as a beacon of scientific research and innovation in Argentina.
The Instituto Leloir’s story began in 1947. Dr. Luis Federico Leloir founded it. He aimed to improve lives through basic research. The institute was first named Instituto de Investigaciones Bioquímicas Fundación Campomar. Textile businessman Jaime Campomar supported it financially.
Initially, the Instituto Leloir was in a old house on Julián Álvarez Street. Today, over 200 researchers work here. They are supported by a staff of technical experts.
Dr. Leloir’s passion inspired many. His team made discoveries impacting science globally. Vanesa Gottifredi, the FIL’s president, says it inspires their work.
The Instituto Leloir grew quickly. It moved twice. In 1958, it moved to Vuelta de Obligado Street. It was here that Leloir learned he had won the Nobel Prize in Chemistry in 1970. In 1983, it moved to its current location in Parque Centenario.
The FIL expanded its research areas over time. Today, it studies cancer, neuroscience, and infectious diseases. It also delves into cellular and developmental biology. Biochemistry, structural biology and bioinformatics are studied here. The goal is to develop health solutions. They also seek technological strategies for agricultural production.
The Instituto Leloir contributes to the community. During the COVID-19 pandemic, its scientists joined the Unidad Coronavirus Covid-19. They developed COVIDAR. This was Argentina’s first serological test for COVID-19. ANMAT approved it in May 2020. It was used for transmission control and healthcare worker protection.
Currently, CoroVaxG.3. is under development. It is a vaccine against SARS-CoV-2 variants. COVIDAR Ag, a rapid antigen test for COVID-19 is being optimized too.
The Leloir Institute demonstrates adaptability. The institute contributes solutions to society’s priorities. Gottifredi believes researchers have already made history. The FIL is deeply involved in its surrounding community. She is confident they will deliver more solutions.
Luis Federico Leloir’s legacy lives on here. He won the Nobel Prize in Chemistry in 1970. His work focused on nucleotides and their role in metabolic pathways. This became known as Leloir’s pathway. It was a significant advance in biochemistry. His discovery identified the cause of galactosemia. If undetected, this congenital disease can cause severe issues.
Today, the Fundacion Instituto Leloir advances scientific knowledge. It remains a key scientific reference point in Latin America. It is a place where dedication betters the human condition.